Gewinn- und Verlustrechnung von UiPath Inc.

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Expand NYSE: PATH UiPath Today's Change (1.08%) $0.13 Current Price $11.68 Key Data Points Market Cap $6.0B Day's Range $11.30 - $11.77 52wk Range $9.20 - $19.84 Volume 1M Avg Vol 38.7M Gross Margin 82.71% UiPath (PATH +1.08%), an agentic automation software platform, closed at $11.69, up 1.21%. The stock was tracking its automation story in premarket trading, and investors are watching the next earnings date as the near-term catalyst.

PATH's Maestro Case launch expands its reach into complex enterprise workflows, deepening its push beyond traditional automation.

PATH's AI orchestration push and growing enterprise adoption make it a more compelling buy over NU despite Nubank's strong fintech growth.

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Expand NYSE: PATH UiPath Today's Change (-1.22%) $-0.13 Current Price $10.14 Key Data Points Market Cap $5.3B Day's Range $10.01 - $10.52 52wk Range $9.20 - $19.84 Volume 916.9K Avg Vol 33.1M Gross Margin 82.71% UiPath (PATH 1.22%), an enterprise automation software provider, closed at $10.15, down 1.07%. UiPath traded lower despite the recent launch of Maestro Case, as investors continued to weigh its agentic automation push against the need for stronger ARR growth.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

PATH is seeing agentic AI move from pilot projects to production deployments, strengthening demand for its automation platform.

NEW YORK--(BUSINESS WIRE)--UiPath, Inc. announces Maestro Case, a new AI-native UiPath agentic case management capability.

The mean of analysts' price targets for UiPath (PATH) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.